| Literature DB >> 20451643 |
Jolita Mereckiene1, Suzanne Cotter, Pierluigi Lopalco, Fortunato D'Ancona, Daniel Levy-Bruhl, Cristina Giambi, Kari Johansen, Luca Dematte, Stefania Salmaso, Pawel Stefanoff, Darina O'Flanagan.
Abstract
In January 2009 25 European Union (EU) Member States (MSs), Norway and Iceland, participated in a survey seeking information on national hepatitis B vaccination programmes. Details of vaccination policy, schedule, population groups targeted for vaccination, programme funding, vaccine coverage and methods of monitoring of vaccine coverage were obtained. Twenty (74%) countries reported that they have a universal hepatitis B vaccination programme, in addition to immunisation of at risk groups; seven (26%) countries recommend HBV for high risk groups only (with some inter-country variation on groups considered at high risk). Among countries without universal hepatitis B vaccination programmes, the major factor for non-introduction is low disease endemicity. 2010 Elsevier Ltd. All rights reserved.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20451643 DOI： 10.1016/j.vaccine.2010.04.037
Source DB: PubMed Journal: Vaccine ISSN： 0264-410X Impact factor: 3.641